DPRXP6

Across TCGA pan-cancer cohorts, DPRXP6 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated DPRXP6 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher DPRXP6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DPRXP6 expression acts as an unfavorable survival marker, although some lineages such as LUAD and MESO show a favorable association.

UVM, LUAD, and KIRC are the cancer types where DPRXP6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	III,IV	0.120	0.854	<.001	81	view →
LUAD	OS	Quartile	All	0.879	0.787	.005	70	view →
KIRC	DFS	Median	All	0.541	0.703	<.001	42	view →
MESO	OS	Median	IV	0.843	0.374	.002	27	view →
LUSC	OS	Tertile	III,IV	0.240	0.580	.001	24	view →
DLBC	DFS	Tertile	II,III,IV	1.000	0.220	.015	16	view →
COAD	OS	Tertile	II,III,IV	0.561	0.804	.027	9	view →
ACC	DFS	Tertile	IV	0.698	0.234	.021	9	view →
LAML	DFS	Median	All	0.681	0.461	.028	6	view →
LIHC	OS	Tertile	II,III,IV	0.537	0.733	.034	6	view →
PCPG	DFS	Tertile	All	1.000	0.761	.048	6	view →
SARC	OS	Quartile	All	0.900	0.727	.016	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

DPRXP6–UVM (OS)

Open the UVM breakdown →